Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1998.5%
operating margin TTM
-2240.9%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.96 |
| peg ratio | -0.01 |
| price to book ratio | 0.65 |
| price to sales ratio | 19.91 |
| enterprise value multiple | -1.62 |
| price fair value | 0.65 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | -2240.9% |
| pretax profit margin | -2078.3% |
| net profit margin | -1998.5% |
| return on assets | -57.1% |
| return on equity | -55.32% |
| return on capital employed | -76.25% |
liquidity ratio | |
|---|---|
| current ratio | 6.16 |
| quick ratio | 6.16 |
| cash ratio | 2.89 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 328.50 |
| days of payables outstanding | 468.66 |
| cash conversion cycle | -140.16 |
| receivables turnover | 1.11 |
| payables turnover | 0.78 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -141.28 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.32 |
| cash per share | 3.75 |
| operating cash flow per share | -2.32 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -141.28 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Lisata Therapeutics, Inc. (NASDAQ:LSTA) reported earnings?
Lisata Therapeutics, Inc. (LSTA) published its most recent earnings results on 12-11-2024.
What is Lisata Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lisata Therapeutics, Inc. (NASDAQ:LSTA)'s trailing twelve months ROE is -55.32%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lisata Therapeutics, Inc. (LSTA) currently has a ROA of -57.1%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LSTA's net profit margin stand at?
LSTA reported a profit margin of -1998.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LSTA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.16 in the most recent quarter. The quick ratio stood at 6.16, with a Debt/Eq ratio of 0.00.